Recent Blog Posts

View Post: Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction ...
6 Nov 2009 by Mandelli, Vignetti, Suciu, Stasi, Petti,...  
Patients and Methods We randomly assigned 2157 patients (age range, 15 to 60 years) to receive intensive induction-consolidation chemotherapy containing either daunorubicin, idarubicin, or mitoxantrone. ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/

---

View Post: high efficacy and low toxicity of apl induction with concurrent ...
6 Sep 2009 by Gulfoncology  
... previously untreated apl patients in a pilot treatment program consisting of concurrent induction using idarubicin/atra followed by an exclusive outpatient post-remission therapy using single dose of idarubicin and intermittent atra ...
View Blog: Araboncology - http://www.gulfoncology.org/blog/blog.html

---

View Post: Generic Pharmaceuticals and Patents: APP Pharmaceuticals Receives ...
11 Aug 2009 by Amit  
Aug 10, 2009 - APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. FDA to market idarubicin hydrochloride injection in three ...
View Blog: Generic Pharmaceuticals and Patents - http://genericspatent.blogspot.com/

---

View Post: fda approves app pharmaceuticals' idarubicin hci injection
10 Aug 2009 by admin  
app pharmaceuticals, inc., a wholly owned subsidiary of fresenius kabi pharmaceuticals holding, inc. (nasdaq:apcvz), announced today that it has received approval from the us food and drug administration (fda) to market idarubicin ...
View Blog: Medical News Base - http://www.medicalnewsbase.com/

---

View Post: app pharmaceuticals receives approval for idarubicin hci injection
10 Aug 2009 by admin  
... kabi pharmaceuticals holding, inc. (nasdaq:apcvz ), announced today that it has received approval from the us food and drug administration (fda) … biopharmaceuticals, generics, fda app pharmaceuticals, idarubicin, idamycin, pfizer ...
View Blog: Medical Sales Jobs Websites - http://medical-sales-jobs-websites.com/

---

View Post: lauren's library blog - new year, new topics, same blog!
1 Jan 2007 by lauren pressley  
symptoms for bronchitis dolcet tramadol Intensive maintenance with IDAMYCIN (idarubicin hydrochloride for injection, USP) is not recommended in view of the considerable toxicity (including deaths in remission) experienced by patients ...
View Blog: lauren's library blog - http://laurenpressley.com/library/

---

View Post: twice daily fludarabine/ara-c associated to idarubicin, g-csf and ...
30 May 2009 by Marco Montillo, Francesca Ricci, Alessandra...  
in this study 52 patients with relapsed/refractory aml obtained a complete remission (cr) rate of 69.2% after flairg regimen (fludarabine and arabinosylcytosine twice daily, idarubicin, g-csf, atra). this schedule resulted effective and ...
View Blog: Leukemia Research - http://www.lrjournal.com/?rss=yes

---